Baby Blues vs PPD: The Critical Signs You Shouldn’t Ignore

Table of Contents

• Postpartum Blues: Understanding the Transient Experience
• Postpartum Depression (PPD): When Symptoms Persist
• Risk Factors and Etiology of Postpartum Depression (PPD)
• The Critical Distinction: Postpartum Blues, Postpartum Depression, and Postpartum Psychosis
• Postpartum Psychosis: A Medical Emergency
• Screening, Diagnosis, and Intervention
• Treatment Pathways for Postpartum Mood Disorders
• Immediate Crisis Counseling and Referral Services
• Frequently Asked Questions

Baby Blues vs PPD: Symptoms, Causes, and Duration Explained

Baby blues vs PPD is one of the most confusing and misunderstood topics for new moms during the postpartum period. After childbirth, it’s normal to experience emotional ups and downs, but understanding the difference between temporary mood changes and clinical postpartum depression is crucial for your mental health and recovery.

The postpartum period, often called the fourth trimester, introduces profound physical and emotional changes.

You may experience intense joy paired with sudden, overwhelming sadness and irritability. This emotional volatility is common.

This transient experience is often categorized as the “baby blues.” It affects up to 85% of new mothers and typically resolves naturally within the first two weeks post-delivery.

However, it is critically important for new parents and healthcare providers to distinguish between these expected, mild mood disorders and the severe, persistent depression symptoms indicative of Postpartum Depression (PPD).

PPD is a serious mental health condition affecting approximately 1 in 7 women. If symptoms last longer than two weeks, immediate intervention is necessary.

Our focus here is safety and timely behavioral health care. Recognizing the clinical differences, especially the presence of persistent anxiety or intrusive thoughts, dictates the necessary treatment referral and care pathway to find treatment.

Since hormonal shifts play a major role in baby blues vs PPD, explore how balancing hormones postpartum can support emotional stability and recovery.

Postpartum Blues: Understanding the Transient Experience

The majority of new mothers will experience what is commonly known as the Postpartum Blues, often simply called the Baby Blues.

This transient experience affects a vast number of new parents, estimated to be up to 85% of mothers during the initial postpartum period.

This condition is characterized by mild mood swings, tearfulness, anxiety, and general restlessness or irritability.

These postpartum symptoms typically begin within two to five days after childbirth.

They are primarily attributed to the dramatic hormonal fluctuations following delivery, specifically the sudden drop in progesterone and estrogen.

The Baby Blues are self-limiting. They resolve naturally without professional intervention, usually fading completely within 10 to 14 days post-delivery.

While challenging, these symptoms do not significantly impair your essential ability to care for yourself or your infant, distinguishing them from more severe postpartum mood disorders.

If these feelings of anxiety and sadness persist beyond the two-week mark, it is a critical signal that intervention may be necessary to rule out clinical Postpartum Depression.

Postpartum Depression (PPD): When Symptoms Persist

While the Postpartum Blues affect up to 85% of new moms and typically resolve within 14 days, Postpartum Depression (PPD) is a clinically diagnosable mood disorder impacting approximately 1 in 7 women.

This condition is far more serious than transient mood swings. Unlike the blues, PPD requires professional mental health intervention to ensure recovery and safety.

Clinical Features and Duration

The core distinction for providers and parents lies in the severity and duration of the postpartum symptoms. If feelings of sadness, anxiety, irritability, or difficulty sleeping persist beyond the two-week mark, immediate screening for clinical Postpartum Depression is mandatory.

PPD symptoms are often debilitating and significantly interfere with daily functioning, impacting self-care and crucial maternal-infant bonding.

PPD can begin during pregnancy (Perinatal Depression) or anytime within the first year of the postpartum period.

Without proper treatment, PPD can persist for months, or even years. Research highlights that 25% of women diagnosed with depression postpartum were still experiencing depression symptoms three years later.

Recognizing Severe Symptoms and Intrusive Thoughts

The symptom profile for PPD is characterized by persistent, intense emotional distress and functional impairment.

• Profound loss of pleasure in activities previously enjoyed (anhedonia).
• Intense sadness, hopelessness, or feelings of worthlessness.
• Severe, persistent anxiety and panic attacks.
• Significant changes in appetite or persistent difficulty sleeping (insomnia or sleeping too much).

A key indicator of severe PPD is the presence of intrusive thoughts. These are unwanted, often horrific thoughts, which may include fears of harm coming to the baby or thoughts of self-harm. These thoughts are terrifying but are essential to disclose to a provider immediately.

Safety First: Accessing Crisis Counseling and Treatment

PPD is treatable, and nearly all patients improve with proper treatment options like psychotherapy and medication. If you or a loved one is experiencing severe postpartum symptoms or thoughts of self-harm, immediate professional help is necessary.

The SAMHSA (Substance Abuse and Mental Health Services Administration) provides essential resources for behavioral health and crisis support.

If you are in crisis, utilize the 988 Suicide & Crisis Lifeline for immediate crisis counseling and support. You can also use FindTreatment.gov or call the National Helpline for confidential treatment referral for Mental and Substance Use Disorders.

Risk Factors and Etiology of Postpartum Depression (PPD)

Understanding the underlying risk factors for Postpartum Mood Disorders is essential for proactive, preventive care.

For healthcare providers, proactive identification during the prenatal and perinatal period allows for enhanced support and early intervention planning, crucial steps for improving maternal mental health outcomes.

The Role of Prior Mental Health and Genetics

The strongest predictor for developing severe Postpartum Depression is a personal or family history of anxiety or mood disorders.

Individuals with a prior history of depression symptoms, anxiety, or Bipolar Disorder are estimated to be 30% to 35% more likely to develop PPD compared to the general population.

Research conducted by specialized organizations, including the Johns Hopkins Center for Reproductive Psychiatry and the Johns Hopkins Center for Women’s Reproductive Mental Health, confirms the critical role of genetics in PPD risk.

Genetic predisposition plays a substantial role. Researchers have identified specific epigenetic biomarkers, differences in gene activity, that may predict which new mothers are at the highest risk for severe Postpartum Mood Disorders.

Hormonal Fluctuations and Biological Triggers

Hormonal changes are central to the etiology of PPD. The rapid, sudden decline in pregnancy hormones immediately following delivery contributes significantly to the onset of mood disorders.

Specifically, the dramatic drop in the progesterone metabolite allopregnanolone is considered a key biological trigger.

This hormonal mechanism is the target of newer, specialized pharmacotherapies, such as Brexanolone, designed specifically for Postpartum Depression treatment.

Environmental and Social Risk Factors

While biology sets the predisposition, environmental and social stressors often exacerbate the risk of developing clinical depression symptoms and PPD.

Other critical risk factors include:

• Poor social support and feelings of isolation.
• Significant socioeconomic stressors.
• Trauma experienced during childbirth.
• History of Substance use disorders or co-occurring behavioral health issues.

Recognizing these combined risks allows providers to tailor screening protocols, ensuring that the up to 50% of perinatal depression cases that often go undetected due to stigma or reluctance to disclose symptoms are caught early, improving access to treatment and crisis counseling.

Read more on how to manage postpartum depression.

The Critical Distinction: Postpartum Blues, Postpartum Depression, and Postpartum Psychosis

The postpartum period naturally involves significant emotional volatility. However, the critical distinction between transient ‘Baby Blues’ and severe Postpartum Depression (PPD) is a matter of intensity, duration, and impact on daily functioning.

As expert providers and new parents, understanding these differences is essential for recognizing when supportive care is sufficient and when immediate mental health intervention is necessary. These varying levels of Postpartum Mood Disorders require different clinical responses. Use this comparison guide to differentiate between the common, transient symptoms and the diagnosable conditions that require professional treatment referral.

Aspect	Postpartum Blues (Baby Blues)	Postpartum Depression (PPD)	Postpartum Psychosis
Prevalence	Up to 85% of new mothers	Approximately 1 in 7 women (13%)	Extremely rare, 0.1%
Onset	2 to 5 days after birth	Can begin during pregnancy or anytime within the first year (often 4 weeks postpartum)	Rapid onset, usually within the first 2 weeks
Duration	Resolves naturally within 14 days	Persists for weeks or months without treatment	Requires immediate, acute intervention
Severity & Function	Mild mood swings, manageable	Severe depression symptoms, difficulty functioning, intense anxiety	Life-threatening, involves severe impairment and detachment from reality
Intervention Needed	Supportive care, rest	Psychotherapy, medication, support groups	Emergency medical stabilization and specialized psychiatric care

Understanding the Transient Baby Blues

The Postpartum Blues (or Baby Blues) are the most common of the Postpartum Mood Disorders, affecting up to 85% of new mothers. These symptoms are primarily caused by the rapid hormonal shifts following delivery.

Symptoms typically include mild mood swings, weepiness, irritability, and some difficulty sleeping. Crucially, these postpartum symptoms are transient. They begin within a few days after birth and resolve completely within 14 days without the need for formal psychiatric intervention.

If these feelings persist beyond two weeks, it is a key indicator that the condition may be progressing toward clinical Postpartum depression.

When Postpartum Symptoms Signal PPD

Unlike the Baby Blues, clinical Postpartum depression (PPD) is a diagnosable severe mental health condition. PPD affects approximately 1 in 7 women and involves persistent and worsening depression symptoms that last for weeks or months. This is when the symptoms begin to impede a parent’s ability to function and bond with their infant.

Key indicators of PPD include intense and persistent anxiety, severe lack of interest or joy, feelings of hopelessness, and potentially the presence of disturbing Intrusive Thoughts related to the baby’s safety or the mother’s own well-being. The Johns Hopkins Center for Women’s Reproductive Mental Health emphasizes that early diagnosis is critical for improving maternal mental health outcomes.

Without treatment, PPD can persist for months or even years. Research shows that up to 50% of perinatal depression cases remain undiagnosed due to stigma and reluctance to disclose symptoms, highlighting the importance of routine screening during the postpartum period.

Recognizing the Emergency: Postpartum Psychosis

While Postpartum Psychosis is extremely rare (0.1%), it is a psychiatric emergency requiring immediate medical stabilization. It typically presents with a rapid onset within the first two weeks postpartum and involves severe impairment, hallucinations, delusions, and disorganized behavior.

Due to the significant risk of harm to self or infant associated with Postpartum Psychosis, this condition cannot be managed with outpatient support alone. If you or someone you know is experiencing symptoms of psychosis or severe behavioral health crisis, call 911 or utilize emergency resources.

The 988 Suicide & Crisis Lifeline provides free, confidential Crisis counseling and Treatment referral services 24/7. Additionally, the SAMHSA (Substance Abuse and Mental Health Services Administration) National Helpline provides confidential, free, 24/7 information and Treatment referral for individuals and families facing Mental and Substance Use Disorders.

Postpartum Psychosis: A Medical Emergency

While Postpartum Depression (PPD) requires urgent intervention and specialized treatment, Postpartum Psychosis (PPP) is the most severe and rarest form of postpartum mood disorder. It represents a true psychiatric emergency.

This condition affects approximately 0.1% of women, often presenting rapidly within the first few weeks postpartum. Unlike the transient ‘baby blues’ or PPD, the symptoms of psychosis are acute and involve a severe break from reality.

Symptoms include hallucinations (seeing or hearing things that are not there), delusions (false, fixed beliefs), rapid mood shifts, and disorganized behavior. Immediate specialized mental health intervention is required.

Due to the chaotic nature of this condition, there is an exceptionally high risk of suicide and infanticide associated with Postpartum Psychosis. Swift action is critical to protect both the mother and the infant from harm.

If you or someone you know exhibits signs of detachment from reality or severe disorganization, immediate medical attention is non-negotiable. This is not a waiting game for symptoms to resolve.

Call 911 immediately or utilize resources provided by SAMHSA. Contact the 988 Suicide & Crisis Lifeline for immediate crisis counseling and referral services. Getting help immediately saves lives and ensures access to essential behavioral health treatment.

Screening, Diagnosis, and Intervention

Early detection is paramount for improving outcomes for both the parent and the infant.

Despite the critical need for vigilance, up to 50% of perinatal depression cases remain undiagnosed.

This startling statistic underscores the importance of proactive screening and addressing the pervasive stigma surrounding mental health issues.

Swift intervention is the key to differentiating between transient Baby blues and severe Postpartum depression.

The Mandate for Proactive Screening

Routine screening for Postpartum Mood Disorders must be implemented consistently, starting during prenatal visits and continuing throughout the entire postpartum period.

The Center for Behavioral Health Statistics and Quality strongly emphasizes the necessity of consistent screening protocols across all healthcare settings to identify those at risk for Mental and Substance Use Disorders.

Using the Edinburgh Postnatal Depression Scale (EPDS)

The Edinburgh Postnatal Depression Scale (EPDS) remains the gold standard screening tool globally.

This self-report questionnaire helps providers assess the severity of depression symptoms, including persistent sadness, irritability, and difficulty sleeping.

Screening should also look for emerging risk factors, such as a history of anxiety or mood disorders, which significantly increase the likelihood of developing PPD.

Overcoming Stigma and Facilitating Disclosure

We encourage all new parents to be open and honest about their emotional state, even if they fear judgment or feel shame regarding their postpartum symptoms.

Providers must cultivate a safe, non-judgmental environment to facilitate the disclosure of sensitive symptoms, particularly intrusive thoughts.

Addressing the stigma associated with mental health is crucial for ensuring that those experiencing severe postpartum depression or anxiety can quickly get help and receive proper treatment.

When Immediate Intervention is Necessary

If screening reveals severe depression symptoms or signs of Postpartum psychosis, immediate psychiatric referral and specialized treatment are required.

The Substance Abuse and Mental Health Services Administration (SAMHSA) provides vital resources for individuals dealing with severe Behavioral health crises.

If you or someone you know is experiencing suicidal ideation, please utilize the 988 Suicide & Crisis Lifeline for immediate crisis counseling and support.

Providers can utilize resources like FindTreatment.gov to offer prompt treatment referral for Postpartum Mood Disorders.

Treatment Pathways for Postpartum Mood Disorders

Effective treatment for Postpartum Mood Disorders is not only available but highly successful. Recovery is achievable and evidence-based.

Data shows that approximately 98% of patients improve significantly when they receive proper treatment and robust support. Early intervention is the foundation of recovery.

If you recognize that your postpartum symptoms, such as persistent sadness, anxiety, severe irritability, or difficulty sleeping, are lasting longer than two weeks (the typical duration of the Postpartum Blues), it is time to seek professional evaluation.

Evidence-Based Treatment Options for PPD

Treatment plans are highly individualized but generally involve a combination of psychological and pharmacological approaches.

For mild to moderate Postpartum Depression, psychotherapy is often the first line of defense. The goal is to address the underlying mechanisms contributing to your depression symptoms.

Psychological and Support Approaches

Psychotherapy, particularly cognitive behavioral therapy (CBT) and interpersonal therapy (IPT), is highly effective for managing anxiety and mood disturbances.

Support groups offer vital community connection and shared experience, reducing feelings of isolation common during the postpartum period.

If you are experiencing distressing intrusive thoughts, immediate psychological intervention is essential to manage these serious postpartum symptoms.

Pharmacological Management and Reproductive Psychiatry

Antidepressants are often utilized to manage moderate to severe Postpartum Depression. Providers specialized in reproductive psychiatry are crucial for managing pharmacokinetics and ensuring safety during pregnancy and lactation.

Specialized Pharmacotherapy: Brexanolone

A significant advance in addressing severe Postpartum Depression is the specialized medication, Brexanolone.

Brexanolone was the first FDA-approved medication specifically for PPD, introduced in 2019.

This compound is a synthetic version of the neurosteroid Allopregnanolone, designed to rapidly modulate the brain receptors affected by the drastic postpartum hormonal crash, offering swift relief.

Because of potential side effects, including sudden loss of consciousness, Brexanolone requires administration via a 60-hour (two to three day) continuous intravenous infusion in a monitored healthcare setting, often overseen by experts like those affiliated with facilities such as the Johns Hopkins Center for Reproductive Psychiatry.

Immediate Crisis Counseling and Referral Services

If symptoms escalate rapidly, including the onset of hallucinations, disorganized behavior, or thoughts of self-harm, you may be experiencing Postpartum Psychosis. This condition is a medical emergency requiring immediate attention.

The Substance Abuse and Mental Health Services Administration (SAMHSA) provides crucial resources for accessing care for Mental and Substance Use Disorders.

If you or someone you know needs immediate assistance or a treatment referral, these resources are available 24/7. Never hesitate to get help.

• The 988 Suicide & Crisis Lifeline: Provides immediate crisis counseling and support for individuals experiencing suicidal ideation or emotional distress.
• The SAMHSA National Helpline: Offers free, confidential, 24/7, 365-day-a-year information and treatment referral services for individuals facing behavioral health issues.
• FindTreatment.gov: A resource managed by SAMHSA to help locate facilities offering treatment for Mental and Substance Use Disorders near you.

Early intervention is the foundation of recovery and safety for both the parent and the infant. Utilize these critical resources if you need immediate support.

Frequently Asked Questions

What is the critical difference between the “Baby Blues” and Postpartum Depression (PPD)?

The distinction lies primarily in severity, duration, and functional impairment. The “Baby Blues,” or Postpartum Blues, are extremely common, affecting up to 85% of new moms. Symptoms are mild, consisting of weepiness, anxiety, and mood swings, and crucially, they resolve naturally within the first two weeks post-delivery.

In contrast, Postpartum Depression (PPD) affects approximately 1 in 7 women. PPD symptoms, such as persistent sadness, severe anxiety, irritability, and difficulty sleeping, last longer than two weeks, interfere significantly with daily functioning, and impact your ability to bond with the baby. Without treatment, PPD can persist for months or even years, studies show 25% of women may still be experiencing depression three years postpartum.

When do symptoms become severe enough to be considered Postpartum Psychosis?

While PPD is serious, it is distinct from Postpartum Psychosis, which is a psychiatric emergency. Postpartum psychosis is extremely rare, affecting only about 0.1% of new mothers, but requires immediate medical attention due to a high risk of suicide and harm to the infant.

Symptoms develop rapidly, often within the first few days to weeks after delivery. These include hallucinations, delusions, disorganized behavior, and severe confusion. If you or a loved one suspects Postpartum Psychosis, call 911 or the 988 Suicide & Crisis Lifeline immediately. This condition requires specialized care and rapid intervention to ensure safety.

How common are Postpartum Mood Disorders, and why are so many cases missed?

The overall prevalence of perinatal mental health issues is substantial. Incidence rates for Postpartum Mood Disorders vary, but studies indicate that up to 39% of women experience significant distress. Despite this high prevalence, up to 50% of perinatal depression symptoms remain undiagnosed.

This critical gap is often due to stigma, fear of judgment, and reluctance to disclose symptoms like severe irritability, lack of interest, or concerning intrusive thoughts. This highlights the necessity of proactive, routine screening using tools like the Edinburgh Postnatal Depression Scale (EPDS) during prenatal and postpartum visits to ensure early diagnosis and intervention.

What role does specialized pharmacotherapy, like Brexanolone, play in treatment?

Standard treatment for Postpartum Depression involves a combination of psychotherapy, antidepressants, and robust support. However, specialized pharmacotherapy offers targeted relief, especially for severe PPD.

Brexanolone, approved by the FDA, is specifically designed to treat PPD. It is a synthetic version of allopregnanolone, a neurosteroid that regulates mood. It works by addressing the rapid hormonal shift postpartum linked to the onset of depression.

Because of the mechanism of action and potential risks, Brexanolone is administered as a continuous infusion over two to three days in a monitored healthcare setting. This represents a significant advancement in targeted care, complementing the work done by specialized reproductive psychiatry centers like the Johns Hopkins Center for Reproductive Psychiatry.

Understanding the spectrum of postnatal mood changes is vital for ensuring timely intervention. The following covers the clinical differences, risk factors, and treatment paths for Postpartum Mood Disorders.

What is the critical distinction between Postpartum Blues, PPD, and Postpartum Psychosis?

The distinction lies in severity, duration, and functional impairment. The Postpartum Blues (Baby Blues) are transient, affecting up to 85% of new moms. Symptoms are mild (weepiness, anxiety, mood swings) and resolve naturally within the first two weeks post-delivery.

Postpartum Depression (PPD) is a severe, clinical mood disorder affecting approximately 1 in 7 women. PPD symptoms, including persistent sadness, irritability, and difficulty sleeping, last longer than two weeks and significantly interfere with daily function, bonding, and recovery. If left untreated, PPD can persist for months or even years, studies show 25% of women still experience depression three years postpartum.

Postpartum Psychosis is extremely rare (0.1%) but constitutes a medical emergency. Symptoms are severe and rapid, often including hallucinations, delusions, and disorganized behavior. Due to the high risk of self-harm or harm to the baby, immediate medical intervention and hospitalization are non-negotiable.

What is the difference between Postpartum Depression (PPD) and Postpartum Anxiety (PPA)?

While PPD is a type of major depressive episode characterized by persistent sadness, guilt, and fatigue, it frequently coexists with severe Postpartum Anxiety (PPA). Up to 50% of women diagnosed with PPD also experience significant anxiety.

PPA involves excessive, uncontrollable worry, restlessness, and physical symptoms like panic attacks and racing thoughts. Critically, PPA often includes intrusive thoughts, unwanted, frightening mental images, usually centered on the baby’s safety or harm.

Both PPD and PPA are serious Mental health conditions requiring specialized Behavioral health treatment. Recognizing the anxiety component is crucial, as women with a history of anxiety or mood disorders are 30-35% more likely to develop PPD.

What are the key risk factors for developing Postpartum Depression?

PPD is complex, often resulting from a combination of biological, social, and psychological factors. Key risk factors include a personal or family psychiatric history, especially previous episodes of depression or anxiety. Genetic biomarkers, such as epigenetic changes, may also increase susceptibility.

Other significant contributors include:

• Social support deficits and socioeconomic stressors.
• Trauma or complications during childbirth.
• Hormonal fluctuations, particularly the sudden drop in progesterone metabolites postpartum.
• Existing Substance use disorders or chronic health conditions.

How long should I wait before seeking professional help for postpartum symptoms?

If symptoms of sadness, irritability, or crying spells last longer than two weeks, or if the symptoms are severe enough to interfere with your ability to function or bond with your baby, you must seek professional evaluation immediately. This is the clinical marker that differentiates transient Baby Blues from clinical PPD.

If you are experiencing thoughts of self-harm, harm to the baby, or symptoms of Postpartum Psychosis (hallucinations, paranoia), do not wait. Call the 988 Suicide & Crisis Lifeline or emergency services immediately for Crisis counseling and intervention.

Why is routine screening for perinatal depression so important?

Routine screening using tools like the Edinburgh Postnatal Depression Scale (EPDS) is essential because up to 50% of perinatal depression cases remain undiagnosed. This high rate is often due to stigma and a reluctance among new mothers to disclose their true Depression symptoms.

Proactive screening during Pregnancy and throughout the Postpartum period ensures early diagnosis. Early identification is key, as 98% of patients show improvement with proper treatment, which includes psychotherapy, medication, and support groups.

Can PPD affect my baby?

Yes, untreated PPD can negatively impact infant development and the mother-infant bond. PPD can lead to difficulty bonding, decreased responsiveness to infant cues, and potential long-term developmental challenges for the child.

Treating PPD protects both the mother and the infant’s well-being. By addressing your Mental health needs, you ensure a stronger foundation for attachment and cognitive development for your child.

What specialized treatments are available for severe Postpartum Depression?

For severe, acute cases of PPD, specialized pharmacotherapy may be recommended. Brexanolone (Zulresso) is the first FDA-approved medication specifically for PPD, addressing the hormonal mechanism linked to the disorder. It is a synthetic version of the progesterone metabolite allopregnanolone.

Brexanolone is administered as a continuous intravenous infusion over two to three days. It is only available through a restricted program due to the requirement for continuous monitoring during the infusion period, as there is a risk of sudden loss of consciousness.

You should discuss this option with a reproductive psychiatrist familiar with Evidence-Based Practices (EBP) in treating perinatal depression.

What role does research play in understanding PPD?

Research is constantly advancing our understanding of Postpartum Mood Disorders. Experts like Liisa Hantsoo, Ph.D., often associated with the Johns Hopkins Center for Women’s Reproductive Mental Health, focus their work on identifying hormonal and genetic factors that contribute to PPD risk.

This research helps target treatment, improve screening, and develop more effective pharmacotherapies beyond traditional antidepressants.

Where can I find immediate help or treatment referral?

If you or someone you know is struggling with Postpartum symptoms or Mental and Substance Use Disorders, immediate help is available. The U.S. government provides several critical resources:

• 988 Suicide & Crisis Lifeline: Call or text 988 anytime for free, confidential Crisis counseling.
• SAMHSA National Helpline: Call 1-800-662-HELP (4357) for confidential, free, 24/7 information service and Treatment referral for Behavioral health services.
• FindTreatment.gov: Use this resource from SAMHSA to locate facilities for Substance use disorders and Mental health treatment near you.